Company news
Resonance Health Ltd news in 2020
Resonance Health Ltd's news releases, calls and decks from 2020, newest first.
HepaFat-AI Incorporated into Blackford Analysis
December 23, 2020
HepaFat-AI gains US FDA clearance
December 8, 2020
New Pulmonary Embolism AI Solution Developed
October 5, 2020
Execution of Licence Agreement
September 10, 2020
Resonance Health Files New Provisional Patent
May 24, 2020
Market Update
March 30, 2020
Controlled Placement Facility
March 19, 2020
Licencee & Royalty Agreement with 3DR Laboratories
February 3, 2020
Decks in 2020
- Shareholder Meeting (November 2020)
Shareholder meeting · 22 slides · Nov 19, 2020